The invention relates to a CB modulator compound of Formula (I) ##STR00001## or a pharmaceutically acceptable form thereof and a method for use in treating, ameliorating or preventing a CB receptor mediated syndrome, disorder or disease.

 
Web www.patentalert.com

< Nitrogen-containing heteroaryl compounds and methods of user thereof

> Compounds useful for the treatment of diseases

> Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
~ 00516